A carregar...
Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world
INTRODUCTION: Renal cell carcinoma (RCC) is the most common cancer of the kidney accounting for 85% of renal tumors. Metastatic RCC (mRCC) had a poor prognosis and with the introduction of tyrosine-kinase inhibitors, such as sunitinib, pazopanib the outcomes improved. There is only one study reporte...
Na minha lista:
Publicado no: | Indian J Med Paediatr Oncol |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Medknow Publications & Media Pvt Ltd
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5234163/ https://ncbi.nlm.nih.gov/pubmed/28144093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0971-5851.195738 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|